Sum Trading At: ,Primary Metric per Equity / Cash Flow Line Item.: ($9.548,912) M, 29.3 ,Metric Weighted per Price Range / Change, 6.66_4_304 ,Combined Weight Adj Trade Metric, 38.99_22 ,for -($1.4)M Market Cap, for, (0.02) off .08;
Equity $$MM: (10) MinRetGrowth: 0.09 MinRetInv: 0.05 Weighted Cost of Capital: 81.785% Estimated Local Continuing Value, Buyout in $$M: 10.607 Estimated Factor NOT LOCAL in $$M: 0.200136 Estimated ContinuingValue: Annual Sales / Top Line Revenue, Desired / Avg per Buyer$$M: 2.122749 Est Buyout Price : 0.1403_53 0.03, ,Annual Sales Factor Forward. 4.607_12_22, ,Price To. 4.498 Year Turnover Period; Year End 2010 Sales 2M;
Profile: Founded in 1998, with the initial development of its intellectual property base in 1992, BioLife Solutions develops, manufactures, and markets patented hypothermic storage/transport and cryopreservation (freeze) products for cells, tissues, and organs, and also performs contract media manufacturing and contract research and development. The Company's proprietary HypoThermosol and CryoStor platform of biopreservation products are marketed to academic research institutions, hospitals, and commercial companies involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology testing. BioLife's GMP products are serum-free and protein-free, fully defined, and pre-formulated to reduce preservation-induced, delayed-onset cell damage and death.
I like the company; Looking for 3.75 to 4.75 Cents with Volume...[10Q Equity @ (10.100405M) and there could be a merger or acquirer transaction;ie;Still Trade As BLFS; [Speculation per buyout, but Private Equity Buyouts have been doing rather well lately with companies such as BLFS;]
so thinly traded you have to use limits or get screwed. if someone bought 100k shares at market they might drive it up to .50 briefly. i've been watching this one, interesting play but may require stem cell companies to be successful before it can really grow? what do you think?
I believe you are correct. The company will grow as the stem cell, cord blood and bio-tech industries grow. BLFS seems to have the best products for freezing, storing and transporting cells, tissue and organs. I look for the company to grow and eventually will be bought out by a larger company such as Life Technologies. Buy and be patient.